Record title

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Record identifier

TN_cdi_proquest_miscellaneous_1751228450

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228450

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

About this item

Full title

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2015, Vol.16 (5), p.583-594

Record Identifier

TN_cdi_proquest_miscellaneous_1751228450

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1751228450

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228450

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item